Aaron Kantoff Talaris Therapeutics, Inc. (TALS) insider trading activity

TALS Quotes by TradingView

Aaron Kantoff is Director of Talaris Therapeutics, Inc.. Currently has a direct ownership of 45,391 shares of TALS, which is worth approximately $123,463. The most recent transaction as insider was on Oct 24, 2023, when has been sold 7,500 shares (Common Stock) at a price of $11.86 per share, resulting in proceeds of $88,950. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 45.4K
0% 3M change
0% 12M change
Total Value Held $123,463

AARON KANTOFF Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 24 2023
BUY
Open market or private purchase
$88,950 $11.86 p/Share
7,500 Added 14.18%
45,391 Common Stock
Oct 19 2023
BUY
Grant, award, or other acquisition
-
37,891 Added 50.0%
37,891 Common Stock

Also insider at

CNTA
Centessa Pharmaceuticals plc Healthcare
Director
AVTX
Avalo Therapeutics, Inc. Healthcare
Director
AK

Aaron Kantoff

Director
Cheshire, X0

Track Institutional and Insider Activities on TALS

Follow Talaris Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TALS shares.

Notify only if

Insider Trading

Get notified when an Talaris Therapeutics, Inc. insider buys or sells TALS shares.

Notify only if

News

Receive news related to Talaris Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TALS